1. Home
  2. DVA vs KEP Comparison

DVA vs KEP Comparison

Compare DVA & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • KEP
  • Stock Information
  • Founded
  • DVA 1994
  • KEP 1961
  • Country
  • DVA United States
  • KEP South Korea
  • Employees
  • DVA N/A
  • KEP N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • KEP Electric Utilities: Central
  • Sector
  • DVA Health Care
  • KEP Utilities
  • Exchange
  • DVA Nasdaq
  • KEP Nasdaq
  • Market Cap
  • DVA 10.9B
  • KEP 12.1B
  • IPO Year
  • DVA 1995
  • KEP N/A
  • Fundamental
  • Price
  • DVA $136.95
  • KEP $10.71
  • Analyst Decision
  • DVA Hold
  • KEP
  • Analyst Count
  • DVA 4
  • KEP 0
  • Target Price
  • DVA $157.00
  • KEP N/A
  • AVG Volume (30 Days)
  • DVA 736.8K
  • KEP 503.8K
  • Earning Date
  • DVA 08-05-2025
  • KEP 06-27-2025
  • Dividend Yield
  • DVA N/A
  • KEP N/A
  • EPS Growth
  • DVA 14.90
  • KEP 667.18
  • EPS
  • DVA 10.11
  • KEP 5.56
  • Revenue
  • DVA $12,968,524,000.00
  • KEP $64,053,841,898.00
  • Revenue This Year
  • DVA $6.46
  • KEP $5.65
  • Revenue Next Year
  • DVA $3.24
  • KEP $2.21
  • P/E Ratio
  • DVA $13.41
  • KEP $3.81
  • Revenue Growth
  • DVA 5.11
  • KEP 4.91
  • 52 Week Low
  • DVA $131.76
  • KEP $6.68
  • 52 Week High
  • DVA $179.60
  • KEP $11.44
  • Technical
  • Relative Strength Index (RSI)
  • DVA 44.92
  • KEP 54.63
  • Support Level
  • DVA $134.64
  • KEP $10.08
  • Resistance Level
  • DVA $138.26
  • KEP $10.84
  • Average True Range (ATR)
  • DVA 2.71
  • KEP 0.20
  • MACD
  • DVA 0.14
  • KEP -0.10
  • Stochastic Oscillator
  • DVA 54.56
  • KEP 45.96

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About KEP Korea Electric Power Corporation

Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.

Share on Social Networks: